Henni-Karoliina Ropponen

About

Henni-Karoliina Ropponen is based out of Basel, Basel-Stadt, and is the Board of Director of Centauri Therapeutics. Henni-Karoliina previously worked at UTILITY therapeutics as a Board Observer. Henni-Karoliina Ropponen attended the Saarland University. Henni-Karoliina Ropponen has been awarded the Andersonian Centenary Medal Prize.

Investment Focus

Location

Basel, Switzerland